IBM Watson, NY Genome Center partner for artificial intelligence-powered cancer research repository

Usefully integrating genomic data into actual treatment of patients remains a huge stumbling block in what’s expected to be the age of precision medicine. That’s particularly true in cancer treatment, where a particular patient’s tumors can each have their own complex genomics that relate to the treatment strategy as a whole. IBM Watson Health ($IBM) and the New York Genome Center are collaborating to analyze genomic cancer tumor data that will be integrated into patient medical records and, ultimately, used to guide treatment strategies. The company will work with the center’s researchers and collaborators to sequence and analyze DNA and RNA from patients’ tumors and integrate that data back into patient medical records. Watson’s artificial intelligence capabilities will be applied to all this sequencing and clinical data to help enable…


Link to Full Article: IBM Watson, NY Genome Center partner for artificial intelligence-powered cancer research repository